Pain Management

Fosfomycin (Monurol) is an antibiotic that uses a unique mechanism of action to establish its bactericidal activity.

When available treatment guidelines for patients with cancer are followed, 70% to 90% can achieve adequate pain relief.

The FDA is investigating the medical food product for serious adverse effects. A pharmacist can convey this information to patients.

Here are ways for pharmacists to relieve foot and leg aches after a long shift.

Initiation of treatment with guideline-recommended medications within 60 days of fibromyalgia diagnosis was associated with immediate annual healthcare cost savings.

Genome sequencing may be fundamental to eventually offering precision medicine to patients with rheumatoid disease, but it will only reveal part of the patient’s health story.

State and local marijuana laws continue to evolve toward legalization much faster than the scientific community can collect the data to help society weigh the health, safety, and ethical ramifications of these new laws.

The findings demonstrated that female gender, older age, and Caucasian race were the most likely predictors of opioid use in patients with JFMS.

Patients with rheumatoid arthritis (RA) who took biologics or triple therapy had a longer fail time than patients who took methotrexate oral monotherapy, suggesting that these treatments may be a good follow-up to failed first-line methotrexate treatment.

Physician and pharmacist collaboration is key within the complex pain management prescribing landscape.

Golimumab is the only fully-human anti-tumor necrosis factor (TNF) alpha therapy that is administered with a 30-minute infusion.

This year, the FDA is on pace to approve about 38 new medications. Here is a look at 6 of these.

This year, the FDA is on pace to approve about 38 new medications. Here is a look at 6 of these.

Breakthrough pain estimates vary, but as many as 50% of patients diagnosed with cancer and chronic pain have pain levels that are not adequately controlled

Here is how to distinguish between those who need prescriptions to manage pain and those seeking controlled substances for illicit reasons.

The tablets did not get approval for managing fibromyalgia, however, according to a press release from Pfizer.

It is currently the first and only extended-release, intra-articular injection available for OA.

Eliminating barriers to non-drug and non-opioid pain management would reduce the effects of the opioid epidemic.

Postoperative pain management presents a major challenge to patients and health care providers.

Pharmacists are in a prime position to help patients manage acute and chronic pain.

In this video from PainWeek 2017, Hal Blatman, MD, medical director of Blatman Health and Wellness Center, discusses the most common misconceptions that patients have about pain.

In this video from PainWeek 2017, Hal Blatman, MD, medical director of Blatman Health and Wellness Center, discusses whether the FDA should reduce the availability of high-dose opioids in response to the growing opioid abuse epidemic.

In this video from PainWeek 2017, Hal Blatman, MD, medical director of Blatman Health and Wellness Center, discusses the relationship between chronic pain and stress.